Form 4: ACM Research CEO David Wang Sells Shares Under 10b5-1 Trading Plan

ACM Research CEO David Wang sold shares of Class A Common Stock on March 14, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 14, 2024, David H. Wang, CEO, President, and Director of ACM Research, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 13, 2023.
• A total of 76,478 shares were sold at a weighted average price of $27.51, with prices ranging from $27.01 to $27.97.
• An additional 10,611 shares were sold at a weighted average price of $28.38, with prices ranging from $28.10 to $28.53.
• Following these transactions, Wang directly owns 504,018 shares of Class A Common Stock.
• Wang also has indirect ownership through various trusts and family members, including 100,002 shares held by his wife, Jing Chen, 45,837 shares held by his daughter, Sophia Wang, 180,000 shares held by the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children, and 620,001 shares held by the Wang-Chen Family Living Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The share sales could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates